Zahra Davoudi

2PUBLICATIONS
12CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 07, 2026
Variant-selective and pan-RAS inhibitors enhance targeted agent activity in patient-derived multi-cell type tumor spheroids.

|Sep 17, 2025
RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types.

Zahra Davoudi, Thomas S Dexheimer, Nathan P Coussens

Pageof 1

Frequent Collaborators

2 joint publications

Thomas S Dexheimer

2 joint publications

Nathan P Coussens

2 joint publications

Thomas Silvers

2 joint publications

Naoko Takebe